Previous 10 | Next 10 |
home / stock / azn / azn articles
On Sunday night, AstraZeneca Plc (NASDAQ: AZN) presented the Phase 3 FLAURA2 results evaluating Tagrisso plus chemotherapy versus Tagriss...
Benzinga Qualcomm Announces Chip Supply Agreement With Apple Qualcomm Inc (NASDAQ: QCOM) stock is trading higher Monday after the chip design...
Shares in European pharmaceutical giant AstraZeneca Plc (NASDAQ: AZN) are down amid speculations swirling around the potential departure ...
Janssen, a unit of Johnson & Johnson (NYSE: JNJ), released topline results from the three-arm Phase 3 MARIPOSA-2 study eval...
The FDA has issued a complete response letter (CRL) regarding AstraZeneca Plc's (NASDAQ: AZN) supplemental Biologics Licens...
Benzinga Why Facebook News is Shutting Down in Europe: What It Means for Users? Meta Platforms Inc (NASDAQ: META) announced a significant dev...
Benzinga Why Facebook News is Shutting Down in Europe: What It Means for Users? Meta Platforms Inc (NASDAQ: META) announced a significant dev...
On Friday, Judge Thomas Rose, serving in the U.S. District Court for the Southern District of Ohio, opted to step down from the case on the same da...
The Biden administration's move to lower drug prices has prompted a flurry of legal challenges. While legal experts acknowledge the lack of a c...
News, Short Squeeze, Breakout and More Instantly...
2024-07-20 00:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 08:30:07 ET Jefferies analyst issues HOLD recommendation for AZN on July 2, 2024 06:20AM ET. The previous analyst recommendation was Hold. AZN was trading at $77.94 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...